Home

safer medicine

Welcome to ICDD-sas.com

ICDD creates products and services to advance faster in the development of novel therapies.


√ Mitostop Go-no go decision √ Mitosecure Mitochondrial liabilities √ Cellesis Anticipation of clinical tolerance	√ Mitoread Mitochondria as a target √ Mitoselect Disease-modifying drug selection √ Mitoscore Drug repositionning	√ Promembrane® Biomarker discovery technology to promote personalized medicine √ Biomarkers discovery Alzheimer, HIV, FSH

ICDD’s services use the Mitosafe® and the Mitostream® technologies. The Mitosafe® technology is based on a Cellular Biological System approach centered on mitochondrial function. The Mitostream® technology is based on a Cellular Dynamical System approach centered on cell adaptability.